MAJOR PLAYERS IN INDIA IN
THE VACCINE MARKET
1. Serum Institute of India
2. Panacea Biotech
3. Venkateshwara Hatcheries
Private
4. Indian Immunological
5. GlaxoSmithKline
Pharmaceuticals
6. Aventis Pharma
7. Shantha Biotechnics
8. Eli Lilly India
9. Haffkine Bio Pharmaceutical
Corporation Ltd (HBCL)
10. Intervet India
11. Lupin
12. Avesthagen
13. Wyeth
14. Sanofi
15. Merck
world. Serum institute is currently
one of the largest manufacturers
of MMR group of vaccines and
Pentavalent group of vaccines in
the world, present in 147 countries.
This is the second overseas
acquisition for the company after
it bought a plant during 2012 in
Holland.
The rapid growth of the global
vaccine market would lead to
increased competition and experts
say that it would even resemble
the pharmaceutical market. There
would be a distinct first mover
advanta ge for companies launching
their vaccines early in the Indian
market with funding from various
government agencies. Competition
in the market is set to increase
with the entry of more traditional
companies. India must develop its
own national strategies to meet
its vaccination needs within its
budgetary constraints. However,
the new initiatives and new
strategic approach by the regulatory
bodies can build the industry’s
confidence. That in turn will be able
to bring about positive changes to
enable India as an emerging leader
in global vaccine industry.
For the Indian vaccine industry to
continue on the current accelerated
growth path for the next decade as
well, it is critical that the current
strength to proactively embrace
innovation and build pipeline of
complex products is channelized
and intensified in an appropriately
rewarding ecosystem. The current
domination in the low and middle
income vaccine supply has to to
move on and make a competitive
mark in the regulated markets.
BIOVOICENEWS.COM
17